Boltwood Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.73M | Buy |
6,880
+5
| +0.1% | +$1.08K | 0.4% | 57 |
|
|
2026
Q1 | $1.5M | Sell |
6,875
-5
| -0.1% | -$1.11K | 0.38% | 64 |
|
|
2025
Q4 | $1.57M | Sell |
6,880
-16
| -0.2% | -$3.65K | 0.41% | 60 |
|
|
2025
Q3 | $1.6M | Sell |
6,896
-45
| -0.6% | -$9.16K | 0.43% | 56 |
|
|
2025
Q2 | $1.29M | Sell |
6,941
-59
| -0.8% | -$11K | 0.37% | 66 |
|
|
2025
Q1 | $1.47M | Sell |
7,000
-65
| -0.9% | -$12.6K | 0.45% | 58 |
|
|
2024
Q4 | $1.26M | Sell |
7,065
-100
| -1% | -$18.4K | 0.38% | 63 |
|
|
2024
Q3 | $1.41M | Sell |
7,165
-45
| -0.6% | -$8.4K | 0.42% | 62 |
|
|
2024
Q2 | $1.24M | Buy |
7,210
+10
| +0.1% | +$1.66K | 0.39% | 63 |
|
|
2024
Q1 | $1.31M | Sell |
7,200
-274
| -4% | -$47.2K | 0.41% | 66 |
|
|
2023
Q4 | $1.16M | Sell |
7,474
-50
| -0.7% | -$7.29K | 0.38% | 68 |
|
|
2023
Q3 | $1.12M | Sell |
7,524
-120
| -2% | -$17.6K | 0.42% | 63 |
|
|
2023
Q2 | $1.03M | Sell |
7,644
-120
| -2% | -$17.6K | 0.37% | 69 |
|
|
2023
Q1 | $1.24M | Buy |
7,764
+250
| +3% | +$38.2K | 0.46% | 52 |
|
|
2022
Q4 | $1.21M | Sell |
7,514
-172
| -2% | -$26.4K | 0.49% | 52 |
|
|
2022
Q3 | $1.03M | Sell |
7,686
-91
| -1% | -$13.1K | 0.47% | 59 |
|
|
2022
Q2 | $1.19M | Sell |
7,777
-52
| -0.7% | -$7.95K | 0.52% | 58 |
|
|
2022
Q1 | $1.27M | Sell |
7,829
-251
| -3% | -$36.5K | 0.49% | 63 |
|
|
2021
Q4 | $1.09M | Sell |
8,080
-58
| -0.7% | -$6.85K | 0.4% | 79 |
|
|
2021
Q3 | $878K | Sell |
8,138
-150
| -2% | -$17.1K | 0.35% | 85 |
|
|
2021
Q2 | $934K | Sell |
8,288
-176
| -2% | -$19.8K | 0.39% | 82 |
|
|
2021
Q1 | $916K | Sell |
8,464
-142
| -2% | -$15.2K | 0.41% | 77 |
|
|
2020
Q4 | $922K | Hold |
8,606
| – | – | 0.45% | 72 |
|
|
2020
Q3 | $754K | Sell |
8,606
-43
| -0.5% | -$4.05K | 0.42% | 79 |
|
|
2020
Q2 | $849K | Sell |
8,649
-55
| -0.6% | -$4.84K | 0.51% | 66 |
|
|
2020
Q1 | $663K | Sell |
8,704
-520
| -6% | -$44.3K | 0.47% | 74 |
|
|
2019
Q4 | $817K | Hold |
9,224
| – | – | 0.46% | 73 |
|
|
2019
Q3 | $698K | Hold |
9,224
| – | – | 0.44% | 78 |
|
|
2019
Q2 | $671K | Hold |
9,224
| – | – | 0.43% | 78 |
|
|
2019
Q1 | $743K | Hold |
9,224
| – | – | 0.48% | 72 |
|
|
2018
Q4 | $850K | Hold |
9,224
| – | – | 0.58% | 57 |
|
|
2018
Q3 | $872K | Hold |
9,224
| – | – | 0.52% | 61 |
|
|
2018
Q2 | $854K | Sell |
9,224
-200
| -2% | -$19.5K | 0.56% | 60 |
|
|
2018
Q1 | $891K | Sell |
9,424
-1,478
| -14% | -$162K | 0.61% | 54 |
|
|
2017
Q4 | $1.05M | Hold |
10,902
| – | – | 0.64% | 53 |
|
|
2017
Q3 | $968K | Sell |
10,902
-600
| -5% | -$45.7K | 0.63% | 55 |
|
|
2017
Q2 | $834K | Sell |
11,502
-350
| -3% | -$23.5K | 0.56% | 62 |
|
|
2017
Q1 | $772K | Hold |
11,852
| – | – | 0.54% | 65 |
|
|
2016
Q4 | $742K | Hold |
11,852
| – | – | 0.57% | 61 |
|
|
2016
Q3 | $747K | Sell |
11,852
-100
| -0.8% | -$6.47K | 0.6% | 57 |
|
|
2016
Q2 | $740K | Hold |
11,952
| – | – | 0.62% | 58 |
|
|
2016
Q1 | $683K | Hold |
11,952
| – | – | 0.6% | 58 |
|
|
2015
Q4 | $708K | Buy |
11,952
+400
| +3% | +$23K | 0.65% | 52 |
|
|
2015
Q3 | $629K | Buy |
11,552
+148
| +1% | +$9.63K | 0.67% | 49 |
|
|
2015
Q2 | $766K | Sell |
11,404
-116
| -1% | -$7.57K | 0.75% | 46 |
|
|
2015
Q1 | $674K | Hold |
11,520
| – | – | 0.2% | 68 |
|
|
2014
Q4 | $754K | Hold |
11,520
| – | – | 0.22% | 64 |
|
|
2014
Q3 | $665K | Sell |
11,520
-116
| -1% | -$6.44K | 0.2% | 70 |
|
|
2014
Q2 | $657K | Buy |
11,636
+2,770
| +31% | +$145K | 0.19% | 68 |
|
|
2014
Q1 | $456K | Sell |
8,866
-300
| -3% | -$15.2K | 0.14% | 72 |
|
|
2013
Q4 | $484K | Sell |
9,166
-134
| -1% | -$6.59K | 0.16% | 71 |
|
|
2013
Q3 | $416K | Sell |
9,300
-650
| -7% | -$28.8K | 0.15% | 70 |
|
|
2013
Q2 | $411K | Buy |
+9,950
| New | +$435K | 0.17% | 70 |
|
Other funds holding ABBV
Boltwood Capital Management's ABBV Position: Q2 2026 in Review
Boltwood Capital Management increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $1.08K and bringing the position to 6,880 shares worth $1.73M. The position accounts for 0.4% of the portfolio, ranked #57.
Boltwood Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Boltwood Capital Management held 6,880 shares of AbbVie worth $1.73M as of Q2 2026.
- Boltwood Capital Management bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
- AbbVie made up 0.4% of Boltwood Capital Management's portfolio in Q2 2026, its #57 holding.
- Boltwood Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Boltwood Capital Management's 13F filing for Q2 2026, filed 6 Jul 2026.